WFA Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
WFA Asset Management's BMY Position: Q1 2024 in Review
WFA Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 627 shares — an estimated $32.2K sold.
WFA Asset Management first reported a position in BMY in Q1 2023 and held it in 4 quarters. The position peaked at $65.8K in Q1 2023. 2,338 funds tracked by Wall St. Rank hold BMY as of Q1 2024.
- WFA Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
- WFA Asset Management sold 627 Bristol-Myers Squibb shares in Q1 2024, an estimated $32.2K.
- WFA Asset Management first reported a position in Bristol-Myers Squibb in Q1 2023 and held it in 4 quarters.
- WFA Asset Management's Bristol-Myers Squibb position peaked at $65.8K in Q1 2023.
- 2,338 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.
Based on WFA Asset Management's 13F filing for Q1 2024, filed 19 Apr 2024.